About cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate
cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate (PubChem CID 155690950) has the molecular formula C29H32ClN7O3
and a molecular weight of 562.07 g/mol. Its IUPAC name is cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate.
Molecular Properties
| Compound Name | cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate |
| PubChem CID | 155690950 |
| Molecular Formula | C29H32ClN7O3 |
| Molecular Weight | 562.07 g/mol |
| Exact Mass | 561.23 |
| IUPAC Name | cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate |
| SMILES | CC(C)Cn1cc(-c2ccc(Cl)c(C[C@H](NC(=O)OC3CC3)C(=O)Nc3ccc(-c4cncn4C)cc3)c2)nn1 |
| InChI | InChI=1S/C29H32ClN7O3/c1-18(2)15-37-16-26(34-35-37)20-6-11-24(30)21(12-20)13-25(33-29(39)40-23-9-10-23)28(38)32-22-7-4-19(5-8-22)27-14-31-17-36(27)3/h4-8,11-12,14,16-18,23,25H,9-10,13,15H2,1-3H3,(H,32,38)(H,33,39)/t25-/m0/s1 |
| InChIKey | VMOHDBRXWRDJPH-VWLOTQADSA-N |
| XLogP | 5.09 |
| TPSA | 115.96 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 562.07 |
| LogP ≤ 5 | 5.09 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate?
The IUPAC name of cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate (CID 155690950) is cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate.
What is the SMILES notation for cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate?
The canonical SMILES for cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate is CC(C)Cn1cc(-c2ccc(Cl)c(C[C@H](NC(=O)OC3CC3)C(=O)Nc3ccc(-c4cncn4C)cc3)c2)nn1.
What is the InChIKey of cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate?
The InChIKey is VMOHDBRXWRDJPH-VWLOTQADSA-N. The full InChI is InChI=1S/C29H32ClN7O3/c1-18(2)15-37-16-26(34-35-37)20-6-11-24(30)21(12-20)13-25(33-29(39)40-23-9-10-23)28(38)32-22-7-4-19(5-8-22)27-14-31-17-36(27)3/h4-8,11-12,14,16-18,23,25H,9-10,13,15H2,1-3H3,(H,32,38)(H,33,39)/t25-/m0/s1.
What are the key properties of cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate?
cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate has a molecular weight of 562.07 g/mol, XLogP of 5.09, 10 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for cyclopropyl N-[(2S)-3-[2-chloro-5-[1-(2-methylpropyl)triazol-4-yl]phenyl]-1-[4-(3-methylimidazol-4-yl)anilino]-1-oxopropan-2-yl]carbamate is sourced from PubChem (CID 155690950), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).